Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) Dividend History

Orchestra BioMed Holdings, Inc. is a medical device company focused on developing and commercializing innovative solutions for cardiovascular and other medical conditions. The company leverages a combination of proprietary technologies and strategic partnerships to bring minimally invasive and durable devices to market. Its portfolio includes products aimed at improving treatment outcomes and patient quality of life.

150 Union Square Drive, New Hope, PA, 18938
Phone: 646-343-9298
Website: https://www.orchestrabiomed.com

Dividend History

Orchestra BioMed Holdings, Inc. Ordinary Shares currently does not pay dividends

Company News

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

Orchestra BioMed's AVIM therapy has received FDA Breakthrough Device Designation for treating uncontrolled hypertension in patients with increased cardiovascular risk, regardless of pacemaker indication. The company is currently enrolling the BACKBEAT global pivotal study to further evaluate the safety and efficacy of AVIM therapy.

GlobeNewswire Inc.

Featured Companies: MDT
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

Orchestra BioMed presented data at the THT 2025 Conference showing that its AVIM therapy significantly improved echocardiographic markers of diastolic dysfunction, an important component in the development of heart failure, in hypertensive patients.

GlobeNewswire Inc.

Featured Companies: MDT
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

Orchestra BioMed, a biomedical company, announced the appointment of Christopher Cleary, a former Medtronic executive, to its Board of Directors. Cleary brings over three decades of experience in corporate development, mergers, and strategic collaborations, which aligns with Orchestra BioMed's partnership-enabled business model.

GlobeNewswire Inc.

Featured Companies: MDT
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?

Orchestra BioMed Holdings, Inc. (OBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research

Featured Companies: ALKS
All You Need to Know About Orchestra BioMed Holdings, Inc. (OBIO) Rating Upgrade to Buy

Orchestra BioMed Holdings, Inc. (OBIO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research

Dividend data last updated 06/07/2025 20:43:17 UTC